Search results for "EMBER"

showing 10 items of 549 documents

European elections in eight new EU member states

2005

Cheng, K.C., 2003. Growth and recovery in Mongolia during transition. Working Paper 03/217,International Monetary Fund.Freedom House. 2004. Freedom in the world. !http://www.freedomhouse.org/research/freeworld/2004/table2004.pdfO.Globe International, 2004. Free and fair: a report on research conducted among media outlets and theelectorate. Globe International, Ulan Bator.Soros Foundation, 2004. Report on the 2004 electoral campaign (in Mongolian). Soros Foundation, UlanBator.doi: 10.1016/j.electstud.2005.03.003

medicine.anatomical_structureMember statesPolitical sciencePolitical Science and International RelationsmedicineFoundation (evidence)GlobePublic administrationElectoral Studies
researchProduct

Procedural aspects of the organization of the comprehensive European Board of Ophthalmology Diploma examination.

2016

International audience; The comprehensive European Board of Ophthalmology Diploma (EBOD) examination is one of 38 European medical specialty examinations. This review aims at disclosing the specific procedures and content of the EBOD examination. It is a descriptive study summarizing the present organization of the EBOD examination. It is the 3rd largest European postgraduate medical assessment after anaesthesiology and cardiology. The master language is English for the Part 1 written test (knowledge test with 52 modified type X multiple-choice questions) (in the past the written test was also available in French and German). Ophthalmology training of minimum 4 years in a full or associated…

medicine.medical_specialty020205 medical informatics*SpecializationFirst language*OphthalmologyItem bankSpecialtylcsh:Medicine02 engineering and technologyReviewDisclosureEducationGerman03 medical and health sciences*Disclosure0302 clinical medicine[ SDV.MHEP ] Life Sciences [q-bio]/Human health and pathologyOphthalmologySpecialty Boards0202 electrical engineering electronic engineering information engineeringMember statemedicinemedia_common.cataloged_instanceHumansEuropean UnionEuropean unionmedia_commonLanguagelcsh:LC8-6691*Languagelcsh:Special aspects of educationlcsh:Rlanguage.human_languageTest (assessment)EuropeOphthalmologyDisclosure; Europe; Language; Ophthalmology; SpecializationEducation Medical GraduateFamily medicineGeneral Health Professions030221 ophthalmology & optometrylanguageEducational MeasurementDescriptive researchPsychology[SDV.MHEP]Life Sciences [q-bio]/Human health and pathology*EuropeSpecializationJournal of educational evaluation for health professions
researchProduct

Management of giant cell arteritis: Recommendations of the French Study Group for Large Vessel Vasculitis (GEFA).

2016

Abstract Purpose Management of giant cell arteritis (GCA, Horton's disease) involves many uncertainties. This work was undertaken to establish French recommendations for GCA management. Methods Recommendations were developed by a multidisciplinary panel of 33 physicians, members of the French Study Group for Large Vessel Vasculitis (Groupe d’etude francais des arterites des gros vaisseaux [GEFA]). The topics to be addressed, selected from proposals by group members, were assigned to subgroups to summarize the available literature and draft recommendations. Following an iterative consensus-seeking process that yielded consensus recommendations, the degree of agreement among panel members was…

medicine.medical_specialtyConsensusConsensus Development Conferences as TopicGiant Cell ArteritisDiseaseRecommendations03 medical and health sciences0302 clinical medicineLarge vessel vasculitisDiagnosismedicineInternal MedicineHumans030212 general & internal medicineIntensive care medicineExpert TestimonySocieties Medical030203 arthritis & rheumatologyModalitiesbusiness.industryBiologic therapiesGastroenterologyTemporal artery biopsymedicine.diseaseSurgeryTreatmentGiant cell arteritisRegimenAdjunctive treatmentCommittee MembershipFrancebusinessAlgorithmsLa Revue de medecine interne
researchProduct

Rare diseases and orphan drugs: Latvian story

2014

Background Ten years have passed since Latvia became a Member State of the EU in 2004. As a result European regulations, including those related to rare diseases and orphan drugs, have been applied to Latvian legislative system. Orphan diseases have been recognized as a priority area for action in the public health system, though there are significant differences in the national healthcare services for rare diseases among the EU States. This study aims to determine situation in the field of rare diseases in Latvia and compare it with other European countries. Methods We used the national plan for rare diseases, EUCERD reports, Orphanet data, Latvian and European regulations, publicly availa…

medicine.medical_specialtyEconomic growthNational Health ProgramsOrphan Drug ProductionLegislationReviewPharmacologyOrphan drugRare DiseasesPolitical scienceOrphan Drug ProductionHealth caremedicineMember stateHumansOrphan drugsGenetics(clinical)Pharmacology (medical)Genetics (clinical)Medicine(all)business.industryPublic healthLatvianAvailabilityLegislatureGeneral MedicineLegislation DrugAccessibilityLatvialanguage.human_languageEuropelanguagebusinessOrphanet Journal of Rare Diseases
researchProduct

Hormonal and nutritional control of L‐carnitine uptake in myoblastic C2C12 cells

2008

L-Carnitine plays an important role in skeletal muscle bioenergetics, and its bioavailability and thus its import may be crucial for muscle function. We studied the effect of thyroid hormone, insulin, and iron overload, hormones and nutrients known to alter muscle metabolism, on L-carnitine import into C2C12 cells. We report here L-carnitine uptake is increased by thyroid hormones and decreased by iron. Insulin was found to be ineffective in altering the L-carnitine uptake.

medicine.medical_specialtyIron OverloadOrganic Cation Transport ProteinsBioenergeticsPhysiologymedicine.medical_treatmentBiologyCell LineCellular and Molecular NeuroscienceCarnitinePhysiology (medical)Internal medicinemedicineHumansInsulinNutritional Physiological PhenomenaRNA MessengerCarnitineMuscle SkeletalSolute Carrier Family 22 Member 5InsulinThyroidSkeletal muscleMetabolismBlotting NorthernHormonesmedicine.anatomical_structureEndocrinologyTriiodothyronineNeurology (clinical)Iron CompoundsEndocrine glandHormonemedicine.drugMuscle & Nerve
researchProduct

The Nordic Paradox and intimate partner violence against women (IPVAW) in Sweden: A background overview

2019

The global public health problem of intimate partner violence against women (IPVAW) is typically tied to gender inequality. Contrary to what would be expected, however, a 2012 survey conducted by the European Union Agency for Fundamental Rights (FRA) showed lifetime prevalence rates of IPVAW in the Nordic countries which were among the highest of the 28 EU member states, despite these countries being rated as some of the most gender‐equal in the world. The aim of this article is to enable a furthered understanding of this Nordic Paradox through providing an overview of knowledge about IPVAW in Sweden in relation to the apparent paradox. It assembles information on IPVAW prevalence, on Swede…

medicine.medical_specialtyMember statesPublic healthLifetime prevalenceGeneral Social SciencesFundamental rightsGender studiesAgency (sociology)medicineGlobal healthDomestic violencemedia_common.cataloged_instanceSociologyEuropean unionmedia_commonSociology Compass
researchProduct

Practical recommendations for the application of DE 59/2013

2019

The changes introduced with Council Directive 2013/59/Euratom will require European Member States adapt their regulations, procedures and equipment to the new high standards of radiation safety. These new requirements will have an impact, in particular, on the radiology community (including medical physics experts) and on industry. Relevant changes include new definitions, a new dose limit for the eye lens, non-medical imaging exposures, procedures in asymptomatic individuals, the use and regular review of diagnostic reference levels (including interventional procedures), dosimetric information in imaging systems and its transfer to the examination report, new requirements on responsibiliti…

medicine.medical_specialtyPopulationRadiation Dosage030218 nuclear medicine & medical imaging03 medical and health sciencesDose limit0302 clinical medicineOccupational ExposureLens CrystallinemedicineHumansRadiology Nuclear Medicine and imagingMedical physicsEuropean UnionEye lenseducationBSSEuropean Directive EuratomRadiodiagnostic and radiotherapeutic proceduresMedical exposureRadiation protectioneducation.field_of_studymedicine.diagnostic_testbusiness.industryMember statesInterventional radiologyGeneral MedicineRadiation ExposureReference StandardsDirective030220 oncology & carcinogenesisRadiological weaponAccidentalAsymptomatic DiseasesEmergenciesSafetyRadiologybusinessHealth PhysicsLa radiologia medica
researchProduct

Model-specific effects of bumetanide on epileptiform activity in the in-vitro intact hippocampus of the newborn mouse.

2007

The immature brain has a higher susceptibility to develop seizures, which often respond poorly to classical pharmacological treatment. It has been recently suggested that bumetanide, which blocks Na(+)-dependent K(+)-Cl(-)-cotransporter isoform 1 (NKCC1) and thus attenuates depolarizing GABAergic responses, could soothe epileptiform activity in immature nervous systems. To evaluate whether bumetanide consistently attenuates epileptiform activity, we investigated the effect of 10 microM bumetanide in five different in-vitro epilepsy models using field potential recordings in the CA3 region of intact mouse hippocampal preparations at postnatal day 4-7. Bumetanide reduced amplitude and frequen…

medicine.medical_specialtySodium-Potassium-Chloride SymportersHippocampusKainate receptorHippocampal formationIn Vitro TechniquesHippocampusMembrane PotentialsCellular and Molecular Neurosciencechemistry.chemical_compoundEpilepsyMiceChloride ChannelsInternal medicinemedicineAnimalsSolute Carrier Family 12 Member 2MagnesiumBumetanidePharmacologyEpilepsyDepolarizationStrychninemedicine.diseaseDisease Models AnimalEndocrinologychemistryAnimals NewbornGabazinePotassiumBumetanidemedicine.drugNeuropharmacology
researchProduct

Personality and Defence Mechanisms in Takotsubo Cardiomyopathy

2017

IntroductionTakotsubo cardiomyopathy (TC) is an acute cardiologic syndrome, characterized by specific symptoms and ECG, echocardiographic and enzymatic abnormalities, similar to an acute myocardial infarction, with no hemodynamically significant stenosis at coronary-ventriculography.ObjectiveTo assess personality in TC patients in order to find common psychopathological elements.MethodsA series of consecutive patients suffering from TC hospitalized at the Cardiology Unit of “Ingrassia” Hospital in Palermo in 2013–2014, were included in the study. We used Structured Clinical Interview for Axis I and II, according to DSM-IV TR criteria. Further, the Defense Mechanisms Inventory (DMI), used in…

medicine.medical_specialtymedia_common.quotation_subjectCardiomyopathyInfarctionmedicine.diseasePsychiatry and Mental healthStenosisFamily memberSample size determinationInternal medicinemedicinePersonalityMyocardial infarctionPsychologyPsychiatrymedia_commonPsychopathologyEuropean Psychiatry
researchProduct

Constitutive androstane receptor activation stimulates faecal bile acid excretion and reverse cholesterol transport in mice.

2010

The constitutive androstane receptor (CAR) is a nuclear receptor expressed in the liver and involved in xenobiotic metabolism. The aim of this study was to assess whether pharmacological CAR activation could affect neutral sterol and bile acid elimination under conditions of cholesterol overload.Wild type, Car-/-, ApoE-/-, and low-density lipoprotein receptor (Ldlr)-/- mice fed a western-type diet were treated with the CAR agonist TCPOBOP.CAR activation was associated with a decrease in faecal cholesterol output related to the repression of the Abcg5/g8 cholesterol transporters. In contrast, TCPOBOP treatment induced a marked increase (up to three fold, p0.01) in the elimination of faecal b…

medicine.medical_specialtymedicine.drug_classPyridinesLipoproteinsBiological Transport ActiveGene ExpressionReceptors Cytoplasmic and NuclearHyperlipidemiasBiologyCholesterol 7 alpha-hydroxylaseBile Acids and Saltschemistry.chemical_compoundFecesMiceApolipoproteins EInternal medicineConstitutive androstane receptormedicineAnimalsHomeostasisATP Binding Cassette Transporter Subfamily G Member 5Liver X receptorConstitutive Androstane ReceptorMice KnockoutHepatologyBile acidCholesterolReverse cholesterol transportATP Binding Cassette Transporter Subfamily G Member 8Cholesterol HDLAtherosclerosisSterolMice Inbred C57BLEndocrinologyCholesterolchemistryLiverReceptors LDLLDL receptorlipids (amino acids peptides and proteins)ATP-Binding Cassette TransportersJournal of hepatology
researchProduct